Name: Measurement of Mitochondrial Mass and Membrane Potential in Hematopoietic Stem Cells and T-cells by Flow Cytometry (Video) | JoVE Journal
Uploaded: 2019-12-26T14:00:00.000+00:00
Duration: 7 min 57 s
Description: Learn flow cytometry-based measurement of mitochondrial mass and membrane potential in hematopoietic stem cells and T-cells. This method enables metabolic profiling of rare cell populations for bone marrow transplantation research.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

We thank the UNIL Flow Cytometry Core Facility for their support especially Dr. Romain Bedel. This work was supported by the Kristian Gerhard Jebsen foundation grant to N.V and O.N.

All experiments described in the manuscript follow the guidelines of our institution and were carried out in accordance with Swiss law for animal experimentation (Authorization: VD3194) and for research involving human samples (Protocol: 235/14; CER-VD 2017-00490)
1. Hematopoietic Stem Cell Extraction
<ol>
	<li>Purchase wild type C57BL6/J mice and keep them in the animal house for at least a week to reduce transport-associated stress.</li>
	<li>On the day of the experiment, euthanize the mouse using CO2 asphyxiation.</li>
	<li>Spray the mouse with 70% ethanol to sterilize the fur and cut open the mouse at the belly using standard surgical tools, such as dissection scissors and forceps, to cut the femur and tibia bones from the hind legs.</li>
	<li>Remove the muscles attached to the femur, tibia, and the pelvis using a soft paper towel and place the cleaned bones in a 50 mL tube containing PBS with 1 mM EDTA (buffer) on ice.</li>
	<li>Spray a mortar and pestle with 70% ethanol and place it in a cell culture hood. Sterilize it with UV for 30 min. Post sterilization rinse the mortar and pestle with buffer to remove traces of ethanol.</li>
	<li>Put the clean bones with some buffer (~10 mL) in the mortar and gently crush them to get the bone marrow out in suspension. Now, collect the cell suspension and pass it through a 70 &#181;m cell strainer into a 50 mL tube to get a single cell suspension.</li>
	<li>Repeat step 1.6 until all the bone marrow has been extracted and the bone debris has turned white.</li>
	<li>Place the 50 mL tube(s) containing the bone marrow single cell suspension on a centrifuge. Run the centrifuge at 300 x g for 10 min at 4 &#176;C to pellet the cells.</li>
	<li>Meanwhile, prepare 10 mL of 1x RBC lysis buffer in autoclaved distilled water. Filter the solution through a 0.22 &#181;m filter.</li>
	<li>Collect the sample tube from the centrifuge and decant the supernatant. Pipette the 1x RBC lysis buffer (Table of Materials) on the cell pellet. Dislodge the pellet and prepare a homogenous solution by pipetting up and down a few times. Allow the tube to be at room temperature for 1&#8211;2 min for the RBC lysis to occur. Stop the lysis process by filling up the tube with the buffer.</li>
	<li>Place the tube on a centrifuge and spin at 300 x g for 5 min at 4 &#176;C. Collect the tube from the centrifuge and decant the supernatant. Resuspend the pellet by adding 10 mL of buffer and filter the solution into a new 50 mL tube via a 70 &#181;m cell strainer to remove the debris due to RBC lysis.</li>
	<li>Centrifuge the tube at 300 x g for 5 min at 4 &#176;C. Collect the tube from the centrifuge and decant the supernatant. Resuspend the pellet in 500 &#181;L of buffer.</li>
	<li>Remove a 100 &#181;L aliquot and keep in a separate 1.5 mL tube. Add 50 &#181;L of biotin lineage depletion antibody cocktail from the progenitor enrichment kit (Table of Materials) to the remaining 450 &#181;L of cell suspension. Incubate at 4 &#176;C on a shaker for 15 min.</li>
	<li>Add 15 mL of buffer and centrifuge the tube at 300 x g for 5 min at 4 &#176;C. Collect the tube from the centrifuge and decant the supernatant. Resuspend the pellet in 460 &#181;L of buffer. Remove a 10 &#181;L aliquot and keep in a separate 1.5 mL tube.</li>
	<li>Add 50 &#181;L of streptavidin magnetic beads from the progenitor enrichment kit (Table of Materials), to the remaining 450 &#181;L cell suspension. Incubate at 4 &#176;C on a shaker for 15 min.</li>
	<li>Add 15 mL of buffer and centrifuge the tube at 300 x g for 5 min at 4 &#176;C. Collect the tube from the centrifuge and decant the supernatant. Resuspend the pellet in 5 mL of buffer and transfer the solution to a 15 mL tube.</li>
	<li>Take the tube to an automated cell separator (Table of Materials). Run a wash program to rinse and prime the tubing of the cell separator. Place the sample and two collection tubes on the tube holder. Perform separation using the &#34;Deplete&#34; program. Collect the positive and the negative fractions from the automated cell separator once the run has ended. 
	NOTE: In the absence of an automatic cell separator the users can use manual magnetic columns and corresponding magnets, per the user manual. The users should keep in mind that the process of manual separation is slower than the automated one. Also, the manual columns are more prone to clogging. Therefore, users are advised to dilute the sample and load on the column slowly.</li>
	<li>Discard the positive fraction. Fill the negative fraction tube with buffer. Centrifuge the tube at 300 x g for 5 min at 4 &#176;C.</li>
	<li>Meanwhile, prepare the antibody mix in 1 mL of final volume solution and the single-color controls in 200 &#181;L of final volume solution as described in Table of Materials and Table 1. 
	NOTE: If the TMRM and the green fluorescent mitochondrial stain are to be combined with stem cell marker staining, then replace CD150-PE with CD150-PEcy5 and Streptavidin-Tx red with Streptavidin-Pac Orange.</li>
	<li>Collect the sample tube from the centrifuge and decant the supernatant. Resuspend the pellet in 1 mL of antibody mix. Add 10 &#181;L of cells (from step 1.13) in each of the single-color control tubes (except lineage). Add 10 &#181;L of cells (from step 1.14) in the lineage single color tube.</li>
	<li>Incubate the sample and single-color control tubes at 4 &#176;C on a shaker for 45 min. Cover the ice bucket with a lid or aluminum foil.</li>
	<li>Fill all tubes with buffer and centrifuge at 300 x g for 5 min at 4 &#176;C. Discard the supernatant and resuspend the sample in 1 mL of buffer and single-color controls in 200 &#181;L of buffer.</li>
	<li>Transfer the sample and the single-color controls to 5 mL filter top FACS tubes.</li>
	<li>Take the tubes to the sorting machine and sort the HSC population (gating strategy in Figure 1A) in 1.5 mL tubes containing 400 &#181;L of stem cell expansion medium.</li>
</ol>
2. Ex Vivo Culture of Hematopoietic Stem Cells
<ol>
	<li>Collect tubes containing sorted cells (see section 1 for cell extraction). Centrifuge the tubes at 300 x g for 5 min at 4 &#176;C. Gently remove most of the supernatant without dislodging the pellet and leave 50&#8211;80 &#181;L on top of the cell pellet. This minimizes cell loss.</li>
	<li>Resuspend the cell pellet in stem cell expansion medium to a final volume dependent on the number of conditions to be tested (count for 100 &#181;L per well/condition of culture).</li>
	<li>Prepare a 2x culture medium containing stem cell expansion medium, stem cell factor (200 ng/mL), FLT3 ligand (4 ng/mL) and pen-strep antibiotics (1%) (2x basal medium; Table of Materials).</li>
	<li>Take a sterile tissue culture treated 96 U-bottom well plate (Table of Materials) and identify the wells where the cells will be cultured (plate design in Figure 1B). 
	NOTE: Users are advised to avoid marginal wells, as they are more susceptible to evaporation.</li>
	<li>Put 100 &#181;L of 2x basal medium previously prepared in step 2.3 in these wells. In the NR marked well add 2 &#181;L of a 100x NR solution (Table of Materials). Replenish NR every 24 h. 
	NOTE: Replenishment is specific to NR. Other metabolic modulators may or may not need replenishment.</li>
	<li>Seed 100 &#181;L of cells prepared in step 2.2 on top of the wells containing 2x basal medium. In this experiment the number of HSCs seeded per well were between 800&#8211;1,000 cells.</li>
	<li>Prepare five extra wells containing 2x basal medium. In each of these add 100,000 whole bone marrow cells (from step 1.13) resuspended in 100 &#181;L of stem cell expansion medium to be used as staining controls for post culture flow cytometry analysis. 
	NOTE: If users want to combine stem cell markers and mitochondrial markers for post culture analysis it is recommended to additionally sort the progenitor population (either Ckit+ cells or LKSCD150- cells). Seed these sorted progenitors in the staining control wells for post culture flow cytometry analysis. Prepare one well per single stain color.</li>
	<li>Put 200 &#181;L of autoclaved water in all surrounding wells to reduce evaporation from wells containing cells. Leave the plate undisturbed in an incubator at 37 &#176;C and 5% CO2 for the duration of the culture period (72 h). Remove the plate to replenish NR every 24 h and place it back in the incubator.</li>
</ol>
3. Measurement of Mitochondrial Mass and Membrane Potential
<ol>
	<li>At the end of the culture period prepare a 100x solution of TMRM (20 &#181;M) and Mitotracker green (10 &#181;M) (green fluorescent stain) in stem cell expansion medium (Table of Materials).</li>
	<li>Add 2 &#181;L of 100x TMRM solution and 2 &#181;L of 100x green fluorescent stain solution in each of the test wells. Add 2 &#181;L of 100x TMRM in the TMRM control well. Add 2 &#181;L of 100x green fluorescent stain in the Mitotracker control well. Place the plate back in an incubator at 37 &#176;C and 5% CO2 for 45 min. Cover the top of the plate with aluminum foil. 
	NOTE: An additional control with Verapamil (ABC pump inhibitor) can be prepared if ABC pump mediated dye efflux needs to be tested. For this, add 50 &#181;M Verapamil in one of the test wells 1 h before staining for TMRM and green fluorescent stain.</li>
	<li>Remove the plate from the incubator and centrifuge it at 300 x g for 5 min. Invert the plate to remove the supernatant. Add 200 &#181;L of standard FACS buffer (PBS-1 mM EDTA-P/S-2% FBS), centrifuge the plate at 300 x g for 5 min. Remove the supernatant. Repeat this washing step 3x. The users must ensure that the plate is always covered with foil, to provide minimal exposure to direct light. 
	NOTE: If users need to combine the mitochondrial staining with stem cell staining, the sample will need to be incubated with an antibody mix of all stem cell markers and the single-color controls will need to be stained with individual antibodies separately at 4 &#176;C for 30&#8211;45 min. 
	NOTE: At all steps users must keep the plate covered with aluminum foil. Users must note that this additional staining step and subsequent washing steps can result in additional cell loss.</li>
	<li>Resuspend the cells in 200 &#181;L of FACS buffer and transfer to FACS tubes.</li>
	<li>Run the samples on the flow cytometer (see Figure 1). Single color tubes containing WBM include: (1) Unstained; (2) DAPI; (3) TMRM (PE); (4) green fluorescent stain (FITC); (5) Full stain (PE and FITC).</li>
	<li>First acquire the single-color controls to set up the machine. Use the running software on the machine to calculate the compensation. Once compensation has been applied, acquire the HSC sample and record as many events as possible. 
	NOTE: If the stem cell and mitochondrial markers are combined, the users need to be particularly careful with compensation between TMRM (PE), CD150 (PE-Cy5), and Sca-1 (APC). Also, the samples should be run immediately post staining.</li>
	<li>Export the FACS files from the cytometer and analyze the data on an analysis software (Table of Materials).
	<ol>
		<li>For the analysis, open the file on the analysis software. Using FSC-A and SSC-A gating identify the cell population. Identify singlets in the next gates before plotting the DAPI negative fraction (live cells). In the live cell gate make a contour plot in the TMRM and green fluorescent stain channel to measure &#916;&#936;m and mass, respectively (Figure 2A). Export the mean fluorescence intensity (MFI) of these two channels in the live cell gate.</li>
		<li>The TMRM low gate is set based on the shoulder population in the TMRM channel. The TMRM single-color control can be used to identify this shoulder population to set the gate. Export the proportion of live of cells in the TMRM low gate in your control and test samples for plotting.</li>
	</ol>
	</li>
</ol>

<ol><li>Busch, K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Fundamental+properties+of+unperturbed+haematopoiesis+from+stem+cells+in+vivo%5BTitle%5D)+AND+%22Nature%22%5BJournal%5D)">Fundamental properties of unperturbed haematopoiesis from stem cells in vivo.</a> Nature. 518 (7540), 542-546 (2015).</li>
<li>Simsek, T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+distinct+metabolic+profile+of+hematopoietic+stem+cells+reflects+their+location+in+a+hypoxic+niche%5BTitle%5D)+AND+%22Cell+Stem+Cell%22%5BJournal%5D)">The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche.</a> Cell Stem Cell. 7 (3), 380-390 (2010).</li>
<li>Takubo, K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Regulation+of+glycolysis+by+Pdk+functions+as+a+metabolic+checkpoint+for+cell+cycle+quiescence+in+hematopoietic+stem+cells%5BTitle%5D)+AND+%22Cell+Stem+Cell%22%5BJournal%5D)">Regulation of glycolysis by Pdk functions as a metabolic checkpoint for cell cycle quiescence in hematopoietic stem cells.</a> Cell Stem Cell. 12 (1), 49-61 (2013).</li>
<li>Yu, W. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Metabolic+regulation+by+the+mitochondrial+phosphatase+PTPMT1+is+required+for+hematopoietic+stem+cell+differentiation%5BTitle%5D)+AND+%22Cell+Stem+Cell%22%5BJournal%5D)">Metabolic regulation by the mitochondrial phosphatase PTPMT1 is required for hematopoietic stem cell differentiation.</a> Cell Stem Cell. 12 (1), 62-74 (2013).</li>
<li>Chen, C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((TSC-mTOR+maintains+quiescence+and+function+of+hematopoietic+stem+cells+by+repressing+mitochondrial+biogenesis+and+reactive+oxygen+species%5BTitle%5D)+AND+%22Journal+of+Experimental+Medicine%22%5BJournal%5D)">TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species.</a> Journal of Experimental Medicine. 205 (10), 2397-2408 (2008).</li>
<li>Ito, K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Regulation+of+oxidative+stress+by+ATM+is+required+for+self-renewal+of+haematopoietic+stem+cells%5BTitle%5D)+AND+%22Nature%22%5BJournal%5D)">Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells.</a> Nature. 431 (7011), 997-1002 (2004).</li>
<li>Ito, K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Reactive+oxygen+species+act+through+p38+MAPK+to+limit+the+lifespan+of+hematopoietic+stem+cells%5BTitle%5D)+AND+%22Nature+Medicine%22%5BJournal%5D)">Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells.</a> Nature Medicine. 12 (4), 446-451 (2006).</li>
<li>Tothova, Z., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((FoxOs+are+critical+mediators+of+hematopoietic+stem+cell+resistance+to+physiologic+oxidative+stress%5BTitle%5D)+AND+%22Cell%22%5BJournal%5D)">FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress.</a> Cell. 128 (2), 325-339 (2007).</li>
<li>Vannini, N., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Specification+of+haematopoietic+stem+cell+fate+via+modulation+of+mitochondrial+activity%5BTitle%5D)+AND+%22Nature+Communications%22%5BJournal%5D)">Specification of haematopoietic stem cell fate via modulation of mitochondrial activity.</a> Nature Communications. 7, (2016).</li>
<li>Vannini, N., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+NAD-Booster+Nicotinamide+Riboside+Potently+Stimulates+Hematopoiesis+through+Increased+Mitochondrial+Clearance%5BTitle%5D)+AND+%22Cell+Stem+Cell%22%5BJournal%5D)">The NAD-Booster Nicotinamide Riboside Potently Stimulates Hematopoiesis through Increased Mitochondrial Clearance.</a> Cell Stem Cell. 24 (3), 405(2019).</li>
<li>Gratwohl, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Risk+score+for+outcome+after+allogeneic+hematopoietic+stem+cell+transplantation%3A+a+retrospective+analysis%5BTitle%5D)+AND+%22Cancer%22%5BJournal%5D)">Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis.</a> Cancer. 115 (20), 4715-4726 (2009).</li>
<li>Gooley, T. A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Reduced+Mortality+after+Allogeneic+Hematopoietic-Cell+Transplantation%5BTitle%5D)+AND+%22New+England+Journal+of+Medicine%22%5BJournal%5D)">Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation.</a> New England Journal of Medicine. 363 (22), 2091-2101 (2010).</li>
<li>Rosenberg, S. A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Durable+complete+responses+in+heavily+pretreated+patients+with+metastatic+melanoma+using+T+cell+transfer+immunotherapy%5BTitle%5D)+AND+%22Clinical+Cancer+Research%22%5BJournal%5D)">Durable complete responses in heavily pretreated patients with metastatic melanoma using T cell transfer immunotherapy.</a> Clinical Cancer Research. 17 (13), 4550-4557 (2011).</li>
<li>Aranda, F., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Trial+Watch%3A+Adoptive+cell+transfer+for+anticancer+immunotherapy%5BTitle%5D)+AND+%22Oncoimmunology%22%5BJournal%5D)">Trial Watch: Adoptive cell transfer for anticancer immunotherapy.</a> Oncoimmunology. 3, 28344(2014).</li>
<li>Wherry, E. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((T+cell+exhaustion%5BTitle%5D)+AND+%22Nature+Immunology%22%5BJournal%5D)">T cell exhaustion.</a> Nature Immunology. 12 (6), 492-499 (2011).</li>
<li>Ho, P. C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Phosphoenolpyruvate+Is+a+Metabolic+Checkpoint+of+Anti-tumor+T+Cell+Responses%5BTitle%5D)+AND+%22Cell%22%5BJournal%5D)">Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses.</a> Cell. 162 (6), 1217-1228 (2015).</li>
<li>Chang, C. H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Metabolic+Competition+in+the+Tumor+Microenvironment+Is+a+Driver+of+Cancer+Progression%5BTitle%5D)+AND+%22Cell%22%5BJournal%5D)">Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression.</a> Cell. 162 (6), 1229-1241 (2015).</li>
<li>van der Waart, A. B., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Inhibition+of+Akt+signaling+promotes+the+generation+of+superior+tumor-reactive+T+cells+for+adoptive+immunotherapy%5BTitle%5D)+AND+%22Blood%22%5BJournal%5D)">Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy.</a> Blood. 124 (23), 3490-3500 (2014).</li>
<li>Crompton, J. G., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Akt+inhibition+enhances+expansion+of+potent+tumor-specific+lymphocytes+with+memory+cell+characteristics%5BTitle%5D)+AND+%22Cancer+Research%22%5BJournal%5D)">Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics.</a> Cancer Research. 75 (2), 296-305 (2015).</li>
<li>de Almeida, M. J., Luchsinger, L. L., Corrigan, D. J., Williams, L. J., Snoeck, H. W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Dye-Independent+Methods+Reveal+Elevated+Mitochondrial+Mass+in+Hematopoietic+Stem+Cells%5BTitle%5D)+AND+%22Cell+Stem+Cell%22%5BJournal%5D)">Dye-Independent Methods Reveal Elevated Mitochondrial Mass in Hematopoietic Stem Cells.</a> Cell Stem Cell. 21 (6), 725-729 (2017).</li>
<li>Abe, T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Establishment+of+Conditional+Reporter+Mouse+Lines+at+ROSA26+Locus+For+Live+Cell+Imaging%5BTitle%5D)+AND+%22Genesis%22%5BJournal%5D)">Establishment of Conditional Reporter Mouse Lines at ROSA26 Locus For Live Cell Imaging.</a> Genesis. 49 (7), 579-590 (2011).</li>
<li>Sukumar, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Mitochondrial+Membrane+Potential+Identifies+Cells+with+Enhanced+Stemness+for+Cellular+Therapy%5BTitle%5D)+AND+%22Cell+Metabolism%22%5BJournal%5D)">Mitochondrial Membrane Potential Identifies Cells with Enhanced Stemness for Cellular Therapy.</a> Cell Metabolism. 23 (1), 63-76 (2016).</li>
<li>Sukumar, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Inhibiting+glycolytic+metabolism+enhances+CD8%2B+T+cell+memory+and+antitumor+function%5BTitle%5D)+AND+%22Journal+of+Clinical+Investigation%22%5BJournal%5D)">Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function.</a> Journal of Clinical Investigation. 123 (10), 4479-4488 (2013).</li>
</ol>

Some elements of this work have been submitted as application P1828EP00 to the European Patent Office.

A tight regulation of HSC function is important to maintain stable hematopoiesis during an organism&#39;s lifetime. Like various other cell types in the body, a key component that contributes to the regulation of HSC function is cellular metabolism. Previous studies from our lab9 and others2,3 have implicated the importance of mitochondria in maintaining a distinct metabolic state in HSCs. Due to the extremely low number of HSCs isolated f...

Hematopoietic stem cells (HSCs) are a small population of cells residing in the bone marrow ensuring blood production and homeostasis throughout an organism&#39;s lifetime. HSCs mediate this process by giving rise to progenitors that in turn produce terminally differentiated mature blood cell lineages via several rounds of cell division and well-orchestrated differentiation steps1. Importantly, HSCs produce their energy via anaerobic glycolysis. In contrast, more committed and active hematopoietic progenitors switch their metabolism toward mitochondrial metabolism2,3,4. This distinct metabolic state is believed to protect the HSCs from cellular damage inflicted by reactive oxygen species (ROS) produced by active mitochondria, thereby maintaining their long-term in vivo function5,6,7,8. Direct measurement of the HSC metabolic state is challenging and often low throughput due to their limited numbers. Here, we describe a flow cytometry-based assay for robust measurement of mitochondrial membrane potential (&#916;&#936;m) using tetramethylrhodamine methyl ester (TMRM) fluorescence, and mitochondrial mass using a green fluorescent mitochondrial stain (Mitotracker Green) in HSCs. We have previously demonstrated that low &#916;&#936;m is a bona-fide functional marker of highly purified HSCs9 and metabolic modulators capable of lowering &#916;&#936;m enhance HSCs function9,10. Here we propose use of our method on HSCs mitochondrial profiling as strategy to identify novel molecules capable of improving the HSCs&#39; long-term blood reconstitution potential.
As an example, we demonstrate that this assay reliably measures the lowering of HSC &#916;&#936;m upon exposure to vitamin B3 analog nicotinamide riboside (NR). Accordingly, in our recently published study we demonstrate that NR strongly ameliorates blood recovery posttransplant in both mouse and humanized mouse systems by directly improving hematopoietic stem and progenitor functions10. The capacity of such metabolic modulators is of great clinical value considering that a 25% death rate is linked to delay in blood and immune recovery in posttransplanted patients11,12.
Moreover, we provide evidence that this methodology can be applied for the characterization of the metabolic profile and function of human T cells. In recent years, the development of adoptive cell therapy (ACT) using autologous tumor infiltrating lymphocytes (TILs) has become the most effective approach for certain types of advanced cancer with extremely unfavorable prognosis (e.g., metastatic melanoma, where &#62;50% of patients respond to treatment and up to 24% of patients have complete regression)13. However, TILs harboring sufficient antitumor activity are difficult to generate14. The extensive proliferation and stimulation that TILs undergo during ex vivo expansion cause T cell exhaustion and senescence that dramatically impair T cell antitumor response15. Importantly, the TILs&#39; antitumoral capacity is tightly linked to their metabolism16,17 and approaches aimed to modulate metabolism through the inhibition of the PI3K/Akt pathway have produced encouraging results18,19. For this reason, we compare the &#916;&#936;m of T cells derived from peripheral blood mononuclear cells (PBMCs) and patient-derived TILs, and show that less differentiated PBMC-derived T cells have lower &#916;&#936;m and mitochondrial mass as compared to terminally differentiated TILs.
We envision that this assay can be used to identify novel metabolic modulators that improve HSC and T cell function via the modulation of &#916;&#936;m.

<table><tbody><tr><td>5 mL FACS tubes</td><td>Falcon</td><td>352235</td><td>Sample preparation</td></tr><tr><td>96-U bottom plate</td><td>Corning</td><td>3799</td><td>Cell culture</td></tr><tr><td>AutoMACS pro separator</td><td>Miltenyi Biotec</td><td></td><td>Automatic Cell separation</td></tr><tr><td>BD FACS AriaIII</td><td>Becton and Dickinson</td><td></td><td>Cell sorting</td></tr><tr><td>BD IMag mouse hematopoietic progenitor cell enrichment kit</td><td>BD</td><td>558451</td><td>Lineage depletion</td></tr><tr><td>BD LSRII</td><td>Becton and Dickinson</td><td></td><td>FACS acquisition machine</td></tr><tr><td>BD-DIVA</td><td>Becton and Dickinson</td><td></td><td>Acquisition software</td></tr><tr><td>CD150 PE</td><td>Biolegend</td><td>115904</td><td>Antibody staining mix</td></tr><tr><td>CD150 PE-Cy5</td><td>Biolegend</td><td>115912</td><td>Antibody staining mix</td></tr><tr><td>CD48 PB</td><td>Biolegend</td><td>103418</td><td>Antibody staining mix</td></tr><tr><td>Centrifuge- 5810R</td><td>Eppendorf</td><td></td><td>Centrifugation</td></tr><tr><td>Ckit PeCy7</td><td>Biolegend</td><td>105814</td><td>Antibody staining mix</td></tr><tr><td>Flow jo</td><td>FlowJo LLC</td><td></td><td>FACS Analysis software</td></tr><tr><td>GraphPad-Prism</td><td>GraphPad</td><td></td><td>Plotting data into graphs</td></tr><tr><td>Mitotracker Green</td><td>Invitrogen</td><td>M7514</td><td>Green-fluorescent mitocondrial stain to measure mitochondrial mass; working concentration = 100 nM; stock concentration = 1 mM</td></tr><tr><td>Nicotinamide Riboside (NR)</td><td>Custom synthesized in house</td><td></td><td>Metabolic modulator; working concentration = 500 &amp;micro;M; stock concentration = 50 mM</td></tr><tr><td>PBS</td><td>CHUV</td><td>1000324</td><td>Buffer preparation; working concentration = 1x; stock concentration = 1x</td></tr><tr><td>Pen-Strep (P/S)</td><td>Life technologies</td><td>15140122</td><td>Ex vivo culture; working concentration = 1x; stock concentration = 1x</td></tr><tr><td>RBC Lysis buffer</td><td>Biolegend</td><td>420301</td><td>Lysing Red blood cells; working concentration = 1x; stock concentration = 10x</td></tr><tr><td>Recombinant Mouse Flt-3 Ligand (FLT3)</td><td>RnD</td><td>427-FL-005/CF</td><td>Ex vivo culture; working concentration = 2 ng/mL; stock concentration = 10 &amp;micro;g/mL</td></tr><tr><td>Recombinant mouse stem cell factor (SCF)</td><td>RnD</td><td>455-MC-010/CF</td><td>Ex vivo culture; working concentration = 100 ng/mL; stock concentration = 50 &amp;micro;g/mL</td></tr><tr><td>Sca1 APC</td><td>Thermo Fisher Scientific</td><td>17-5981-82</td><td>Antibody staining mix</td></tr><tr><td>StemlineII Hematopoietic Stem Cell Expansion Medium</td><td>SIGMA</td><td>S0192</td><td>Ex vivo culture</td></tr><tr><td>Streptavidin Pac orange</td><td>Life Technologies</td><td>S32365</td><td>Antibody staining mix</td></tr><tr><td>Streptavidin Tx red</td><td>Life Technologies</td><td>S872</td><td>Antibody staining mix</td></tr><tr><td>TMRM</td><td>Invitrogen</td><td>T668</td><td>Staining mitochondrial membrane potential; working concentration = 200 nM; stock concentration = 10 mM</td></tr><tr><td>Ultra pure EDTA</td><td>Invitrogen</td><td>15575-038</td><td>Buffer preparation; working concentration = 0.5 M; stock concentration = 1 mM</td></tr></tbody></table>

measurement of mitochondrial mass and membrane potential in hematopoietic stem cells and t-cells by flow cytometry

Measurement of Mitochondrial Mass and Membrane Potential in Hematopoietic Stem Cells and T-cells by Flow Cytometry

A fine balance of quiescence, self-renewal, and differentiation is key to preserve the hematopoietic stem cell (HSC) pool and maintain lifelong production of all mature blood cells. In recent years cellular metabolism has emerged as a crucial regulator of HSC function and fate. We have previously demonstrated that modulation of mitochondrial metabolism influences HSC fate. Specifically, by chemically uncoupling the electron transport chain we were able to maintain HSC function in culture conditions that normally induce rapid differentiation. However, limiting HSC numbers often precludes the use of standard assays to measure HSC metabolism and therefore predict their function. Here, we report a simple flow cytometry assay that allows reliable measurement of mitochondrial membrane potential and mitochondrial mass in scarce cells such as HSCs. We discuss the isolation of HSCs from mouse bone marrow and measurement of mitochondrial mass and membrane potential post ex vivo culture. As an example, we show the modulation of these parameters in HSCs via treatment with a metabolic modulator. Moreover, we extend the application of this methodology on human peripheral blood-derived T cells and human tumor infiltrating lymphocytes (TILs), showing dramatic differences in their mitochondrial profiles, possibly reflecting different T cell functionality. We believe this assay can be employed in screenings to identify modulators of mitochondrial metabolism in various cell types in different contexts.

In Figure 1 we show the gating strategy for the isolation of hematopoietic stem cells from the mouse bone marrow and the layout of the plate for their ex vivo culture. Figure 1A shows the identification of the lymphocyte fraction in the SSC-A/FSC-A plot. Doublets were removed in the singlet gate followed by identification of live cells by the absence of DAPI signal. The LKS population, defined by lineage- Sca1+cKit+, was id...

Here we describe a reliable method to measure mitochondrial mass and membrane potential in ex vivo cultured hematopoietic stem cells and T cells.

A fine balance of quiescence, self-renewal, and differentiation is key to preserve the hematopoietic stem cell (HSC) pool and maintain lifelong production ...

measurement-mitochondrial-mass-membrane-potential-hematopoietic-stem

Research

JoVE Journal

Biology

This video demonstrates the labeling of neuronal cells with antibodies for mitochondrial respiratory chain complexes, mitochondrial DNA-associated protein, and mitochondrial outer membrane protein, followed by flow cytometry to quantify their levels.

Measurement of Multiple Mitochondrial Parameters in Neurons using Flow Cytometry

Described here is a method to detect and quantify mitochondrial outer membrane proteins by immunolabeling of mitochondria isolated from rodent tissue and analysis by flow cytometry. This method can be extended to assess functional aspects of mitochondrial subpopulations.

Immunodetection of Outer Membrane Proteins by Flow Cytometry of Isolated Mitochondria

Here, we present a protocol that uses JC-1 dye to assess the mitochondrial membrane potential of cells after being exposed to hypoxia/reoxygenation with or without a protective agent.

A Flow Cytometry-based Assay for Measuring Mitochondrial Membrane Potential in Cardiac Myocytes After Hypoxia/Reoxygenation

This article illustrates a powerful method to quantify mitochondria or lysosomes in living cells. The combination of lysosome- or mitochondria-specific dyes with fluorescently conjugated antibodies against surface markers allows the quantification of these organelles in mixed cell populations, like primary cells harvested from tissue samples, by using multicolor flow cytometry.

Multicolor Flow Cytometry-based Quantification of Mitochondria and Lysosomes in T Cells

We describe a method for using multiparameter flow cytometry to detect mitochondrial reactive oxygen species (ROS) in murine healthy hematopoietic stem and progenitor cells (HSPCs) and leukemia cells from a mouse model of acute myeloid leukemia (AML) driven by MLL-AF9.

Flow Cytometric Analysis of Mitochondrial Reactive Oxygen Species in Murine Hematopoietic Stem and Progenitor Cells and MLL-AF9 Driven Leukemia

Xenobiotic efflux pumps are highly active in hematopoietic stem and progenitor cells (HSPCs) and cause extrusion of TMRM, a mitochondrial membrane potential fluorescent dye. Here, we present a protocol to accurately measure mitochondrial membrane potential in HSPCs by TMRM in the presence of Verapamil, an efflux pump inhibitor.

Improving the Accuracy of Flow Cytometric Assessment of Mitochondrial Membrane Potential in Hematopoietic Stem and Progenitor Cells Through the Inhibition of Efflux Pumps

Metabolic adaptation is fundamental for T cells as it dictates differentiation, persistence, and cytotoxicity. Here, an optimized protocol for monitoring mitochondrial respiration in ex vivo cytokine-differentiated human primary T cells is presented.

Real-time Monitoring of Mitochondrial Respiration in Cytokine-differentiated Human Primary T Cells

This study reports a novel approach to measure multiple mitochondrial functional parameters based on flow cytometry and double staining with two fluorescent reporters or antibodies to detect changes in mitochondrial volume, mitochondrial membrane potential, reactive oxygen species level, mitochondrial respiratory chain composition, and mitochondrial DNA.

Flow Cytometric Analysis of Multiple Mitochondrial Parameters in Human Induced Pluripotent Stem Cells and Their Neural and Glial Derivatives

Methods for studying mitochondrial bioenergetics under physiologically relevant substrate concentrations in immune cells are limited. We provide a detailed protocol that uses high-resolution fluorespirometry to assess changes in the response of the mitochondrial membrane potential to energy demand in human T-cells, monocytes, and peripheral mononuclear cells.

High-Resolution Fluorespirometry to Assess Dynamic Changes in Mitochondrial Membrane Potential in Human Immune Cells

Isolation and Transplantation of Hematopoietic Stem Cells (HSCs)

Learn flow cytometry-based measurement of mitochondrial mass and membrane potential in hematopoietic stem cells and T-cells. This method enables metabolic profiling of rare cell populations for bone marrow transplantation research.

Measurement of Mitochondrial Mass and Membrane Potential in Hematopoietic Stem Cells and T-cells by Flow Cytometry

Explore More Videos